MPGES-1-derived PGE2 Mediates Dehydration Natriuresis
Overview
Physiology
Authors
Affiliations
PGE(2) is a natriuretic factor whose production is elevated after water deprivation (WD) but its role in dehydration natriuresis is not well-defined. The goal of the present study was to investigate the role of microsomal prostaglandin E synthase-1 (mPGES-1) in dehydration natriuresis. After 24-h WD, wild-type (WT) mice exhibited a significant increase in 24-h urinary Na(+) excretion accompanied with normal plasma Na(+) concentration and osmolality. In contrast, WD-induced elevation of urinary Na(+) excretion was completely abolished in mPGES-1 knockout (KO) mice in parallel with increased plasma Na(+) concentration and a trend increase in plasma osmolality. WD induced a 1.8-fold increase in urinary PGE(2) output and a 1.6-fold increase in PGE(2) content in the renal medulla of WT mice, both of which were completely abolished by mPGES-1 deletion. Similar patterns of changes were observed for urinary nitrate/nitrite and cGMP. The natriuresis in dehydrated WT mice was associated with a significant downregulation of renal medullary epithelial Na channel-α mRNA and protein, contrasting to unaltered expressions in dehydrated KO mice. By quantitative RT-PCR, WD increased the endothelial nitric oxide synthase (eNOS), inducible NOS, and neuronal NOS expressions in the renal medulla of WT mice by 3.9-, 1.48-, and 2.6-fold, respectively, all of which were significantly blocked in mPGES-1 KO mice. The regulation of eNOS expression was further confirmed by immunoblotting. Taken together, our results suggest that mPGES-1-derived PGE(2) contributes to dehydration natriuresis likely via NO/cGMP.
Zhuang Y, Jia Z, Hu C, Ding G, Zhang X, Zhang Y Oncotarget. 2017; 8(44):75808-75821.
PMID: 29100270 PMC: 5652664. DOI: 10.18632/oncotarget.10257.
Soleimani M, Barone S, Xu J, Alshahrani S, Brooks M, McCormack F PLoS One. 2016; 11(7):e0159804.
PMID: 27442254 PMC: 4956050. DOI: 10.1371/journal.pone.0159804.
New Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy.
Jia Z, Sun Y, Yang G, Zhang A, Huang S, Heiney K PPAR Res. 2014; 2014:818530.
PMID: 24624137 PMC: 3927865. DOI: 10.1155/2014/818530.
PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice.
Sun Y, Jia Z, Liu G, Zhou L, Liu M, Yang B PPAR Res. 2014; 2013:612971.
PMID: 24489534 PMC: 3892750. DOI: 10.1155/2013/612971.